您的位置: 首页 > 农业专利 > 详情页

USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
专利权人:
SCICLONE PHARMACEUTICALS; INC.
发明人:
Xiangdong Guan,Jianfeng Wu,Cynthia W. Tuthill
申请号:
US13877323
公开号:
US20150024994A1
申请日:
2013.03.28
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention provides methods for preventing, treating, or reducing the severity of sepsis, severe sepsis or septic shock, including bacterial, viral, and fungal infections, and including infections of more complex etiology. The invention involves the administration of an alpha thymosin peptide regimen. In certain embodiments, the alpha thymosin peptide regimen is scheduled or timed with respect to potential, expected and/or diagnosed sepsis, severe sepsis or septic shock. In certain embodiments, the patient is immunodeficient or immunocompromised, and/or the patient is hospitalized or scheduled for hospitalization, such that the regimen of alpha thymosin peptide helps to protect the patient from, or reduce the severity of, sepsis, severe sepsis or septic shock.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充